Literature DB >> 225344

Characterization of lipotropin-, corticotropin-, and beta-endorphin-immunoreactive materials secreted in vitro by a human pituitary adenoma responsible for a case of Nelson's syndrome.

X Bertagna, J P Luton, M Binoux, H Bricaire, F Girard.   

Abstract

A human pituitary adenoma responsible for a case of Nelson's syndrome was maintained in organ culture and the incubation medium was examined with four different RIAs; human corticotropin (ACTH), beta-MSH, lipotropin (LPH), and beta-endorphin (beta-End). All four immunoreactivites (IRs) were present in the medium obtained after 24 h of incubation. Gel exclusion chromatography under denaturing conditions (6 m guanidine HCl) revealed several immunoreactive components. Two components having both human beta-MSH (beta-hMSH) and human LPH (hLPH) IR coeluted with beta-hLPH and gamma-hLPH; a component with beta-hMSH IR but no hLPH IR coeluted with [125I]beta-hMSH; a component with human ACTH (hACTH) IR eluted at the position of hACTH. Sephadex G-50 gel exclusion chromatography revealed that approximately 80% and 20% of human beta-End (beta-hEnd) IR were accounted for by components coeluting with beta-hLPH and beta-hEnd, respectively. These data demonstrate the presence in this incubation medium of materials similar to if not identical with beta-hLPH, gamma-hLPH, hACTH, beta-hMSH, and beta-hEnd; they suggest that all of these peptides may be secreted in the circulation of patients with Nelson's syndrome.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225344     DOI: 10.1210/jcem-49-4-527

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  A case of pseudo-Nelson's syndrome: cure of ACTH hypersecretion by removal of a bronchial carcinoid tumor responsible for Cushing's syndrome.

Authors:  J D Lalau; D Vieau; F Tenenbaum; P F Westeel; A Mesmacque; F Lenne; J Quichaud
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

2.  Cushing's syndrome in medullary thyroid carcinoma.

Authors:  A Mure; C Gicquel; N Abdelmoumene; F Tenenbaum; C Francese; J P Travagli; P Gardet; M Schlumberger
Journal:  J Endocrinol Invest       Date:  1995-03       Impact factor: 4.256

3.  Simultaneous assay of immunoreactive beta-lipotropin, gamma-lipotropin, and beta-endorphin in plasma of normal human subjects, patients with ACTH/lipotropin hypersecretory syndromes, and patients undergoing chronic hemodialysis.

Authors:  X Y Bertagna; W J Stone; W E Nicholson; C D Mount; D N Orth
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

4.  Long acting somatostatin treatment of paraneoplastic Cushing's syndrome in a case of Zollinger-Ellison syndrome.

Authors:  P Ruszniewski; F Girard; R Benamouzig; M Mignon; S Bonfils
Journal:  Gut       Date:  1988-06       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.